Helixmith Co., Ltd (084990.KQ)
KRW 2770.0
(0.0%)
KRW 2770.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1543.76 KRW | -33.8% |
| 2022 | -1153.75 KRW | 38.12% |
| 2021 | -1864.54 KRW | 27.07% |
| 2020 | -2556.68 KRW | 28.26% |
| 2019 | -3563.91 KRW | -269.45% |
| 2018 | -964.66 KRW | -342.28% |
| 2017 | -218.11 KRW | -730.58% |
| 2016 | -26.26 KRW | -379.96% |
| 2015 | 9.38 KRW | 0.0% |
| 2013 | 10.96 KRW | 105.44% |
| 2012 | -201.31 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -109.33 KRW | 87.51% |
| 2024 Q2 | -92.88 KRW | 15.05% |
| 2023 Q4 | -875.61 KRW | -339.43% |
| 2023 FY | - KRW | -33.8% |
| 2023 Q1 | -263.13 KRW | 5.25% |
| 2023 Q2 | -205.96 KRW | 21.73% |
| 2023 Q3 | -199.26 KRW | 3.25% |
| 2022 FY | - KRW | 38.12% |
| 2022 Q2 | -256.16 KRW | 23.62% |
| 2022 Q3 | -294.34 KRW | -14.9% |
| 2022 Q1 | -335.38 KRW | 47.73% |
| 2022 Q4 | -277.71 KRW | 5.65% |
| 2021 Q3 | -114.54 KRW | 81.45% |
| 2021 Q4 | -641.67 KRW | -460.21% |
| 2021 FY | - KRW | 27.07% |
| 2021 Q2 | -617.60 KRW | -1417.07% |
| 2021 Q1 | -40.71 KRW | 91.65% |
| 2020 FY | - KRW | 28.26% |
| 2020 Q1 | -870.04 KRW | 60.28% |
| 2020 Q2 | -316.15 KRW | 63.66% |
| 2020 Q3 | -531.82 KRW | -68.22% |
| 2020 Q4 | -487.80 KRW | 8.28% |
| 2019 Q2 | 1002.92 KRW | 297.15% |
| 2019 FY | - KRW | -269.45% |
| 2019 Q1 | -508.70 KRW | 18.82% |
| 2019 Q4 | -2190.34 KRW | -430.23% |
| 2019 Q3 | -413.09 KRW | -141.19% |
| 2018 FY | - KRW | -342.28% |
| 2018 Q3 | -216.44 KRW | -186.14% |
| 2018 Q4 | -626.65 KRW | -189.53% |
| 2018 Q2 | -75.64 KRW | 6.47% |
| 2018 Q1 | -80.87 KRW | 47.15% |
| 2017 Q3 | -22.69 KRW | 38.09% |
| 2017 FY | - KRW | -730.58% |
| 2017 Q2 | -36.65 KRW | 33.73% |
| 2017 Q1 | -55.30 KRW | 0.0% |
| 2017 Q4 | -153.02 KRW | -574.39% |
| 2016 FY | - KRW | -379.96% |
| 2015 FY | - KRW | 0.0% |
| 2014 Q1 | -39.25 KRW | -16.4% |
| 2014 Q3 | -27.59 KRW | -264.95% |
| 2014 Q2 | -7.56 KRW | 80.74% |
| 2013 FY | - KRW | 105.44% |
| 2013 Q3 | 45.38 KRW | 95.02% |
| 2013 Q2 | 23.27 KRW | 197.81% |
| 2013 Q1 | -23.79 KRW | 86.54% |
| 2013 Q4 | -33.72 KRW | -174.31% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q4 | -176.71 KRW | -943.48% |
| 2012 Q3 | 20.95 KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Co., Ltd. | -1559.61 KRW | 1.016% |
| iNtRON Biotechnology, Inc. | -292.11 KRW | -428.486% |
| BINEX Co., Ltd. | 151.04 KRW | 1122.087% |
| Bioneer Corporation | -410.19 KRW | -276.352% |
| Anterogen.Co.,Ltd. | -291.93 KRW | -428.812% |
| MEDIPOST Co., Ltd. | 287.00 KRW | 637.895% |
| CrystalGenomics, Inc. | -661.00 KRW | -133.549% |
| Chabiotech Co.,Ltd. | -149.80 KRW | -930.547% |
| Medy-Tox Inc. | 1456.65 KRW | 205.98% |
| Peptron, Inc. | -773.61 KRW | -99.553% |
| Amicogen, Inc. | -583.58 KRW | -164.533% |
| Genexine, Inc. | -1652.14 KRW | 6.56% |
| HLB Therapeutics Co.,Ltd. | -32.12 KRW | -4706.227% |
| LegoChem Biosciences, Inc. | -2595.00 KRW | 40.51% |
| ALTEOGEN Inc. | -65.27 KRW | -2265.191% |
| PharmaResearch Co., Ltd. | 7502.00 KRW | 120.578% |
| SillaJen, Inc. | -179.98 KRW | -757.74% |
| JETEMA, Co., Ltd. | 783.21 KRW | 297.107% |
| OliX Pharmaceuticals,Inc | -1323.81 KRW | -16.615% |
| Genomictree Inc. | -391.00 KRW | -294.824% |
| MedPacto, Inc. | -1664.87 KRW | 7.274% |
| D&D Pharmatech | 409.19 KRW | 477.272% |
| EASY BIO,Inc. | 455.00 KRW | 439.288% |
| GI Innovation, Inc. | -1285.69 KRW | -20.072% |